China vs Ukraine: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
China
0.1%
in 2024
Ukraine
0.1%
in 2024
China rank
112th
Ukraine rank
112th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- China
- Ukraine
How they compare
China currently reports 0.1% against 0.1% in Ukraine, a difference of 0.0%.
Across all 10 years both countries report, Ukraine has been ahead every year.
China ranks 112th and Ukraine ranks 112th of 215 countries.
Ukraine has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | China | Ukraine | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.2% | 0.2% | 0.1% | Ukraine |
| 2020s | 0.1% | 0.1% | 0.0% | Ukraine |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, China or Ukraine?
- China, at 0.1% against 0.1% in Ukraine as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between China and Ukraine?
- 0.0%, with China ahead.
- How many years of comparable data are there for China and Ukraine?
- 10 years are reported by both, from 2015 to 2024.
- How do China and Ukraine rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- China ranks 112th and Ukraine ranks 112th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.